US2012225795A1PendingUtilityA1
Protein markers for detecting liver cancer and method for identifying the markers thereof
Est. expiryJul 7, 2030(~3.9 yrs left)· nominal 20-yr term from priority
Inventors:Sen-Yung Hsieh
G01N 33/57525G01N 2333/71G01N 2333/65
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to the diagnosis of liver cancer. It discloses the use of protein ERBB3 and protein IGFBP2 in the diagnosis of liver cancer. It relates to a method for diagnosis of liver cancer from a liquid sample, derived from an individual by measuring ERBB3 protein and IGFBP2 protein in the sample. Measurement of ERBB3 protein and IGFBP2 protein can, e.g., be used in the early detection or diagnosis of liver cancer.
Claims
exact text as granted — not AI-modified1 . A method for detection of liver cancer, comprising steps of:
a) providing a liquid sample obtained from an individual, b) contacting said sample with an antibody specific for at least one of IGFBP2 protein (SEQ ID NO: 4) under conditions appropriate for formation of a complex between said antibody and at least one of said proteins, and c) correlating an amount of the complex formed in step d) to the detection of liver cancer.
2 - 3 . (canceled)
4 . The method according to claim 1 wherein the liquid sample is whole blood.
5 - 9 . (canceled)Join the waitlist — get patent alerts
Track US2012225795A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.